François Ghiringhelli
Inserm · 1,067 works · 60,997 citations · h-index 110
Top works
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- Calreticulin exposure dictates the immunogenicity of cancer cell death
- Immunological aspects of cancer chemotherapy
- Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
- Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
- The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
- What Is the Role of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade in Patients with Metastatic Melanoma?
- CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative
- Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
- Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
- Immunogenic death of colon cancer cells treated with oxaliplatin
- 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell–Dependent Antitumor Immunity
- Tumor cells convert immature myeloid dendritic cells into TGF-β–secreting cells inducing CD4 + CD25 + regulatory T cell proliferation
- The anticancer immune response: indispensable for therapeutic success?
- CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner
- The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy
- Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells
- A novel dendritic cell subset involved in tumor immunosurveillance
- Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth